Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

In general, treatment for myasthenia gravis may include: Drugs to increase muscle strength. If you have mild to moderate myasthenia gravis, the first thing you doctor may give you is a drug to ...

If you have myasthenia gravis, muscle strength will decrease predictably over the course of testing. You may be given certain medications – edrophonium or neostigmine – as part of the exam.

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) ...

Myasthenia gravis, or MG, is "a chronic autoimmune ... chronic stress, or taking certain medications. In some cases, abnormalities in a small organ called the thymus gland "also appear to ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development ... in patients with generalized myasthenia gravis, a debilitating autoimmune disease ...

Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Myasthenia Gravis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive ...

drugs for the treatment of myasthenia gravis. Thymectomy surgery and plasma exchange may also help. The aim of myasthenia gravis treatments is to help reduce muscle weakness and improve a person ...